Figures show 28% of 111 UK patient groups have a positive impression of pharma firms, attributable to only 43% of groups partnering with them, compared to the global figure of 81%, according to a report by PatientView. The figures also showed that in some countries such as Germany, patients are more likely than others to trust their healthcare providers and doctors when it comes to prescribing medicines.
Figures show 28% of 111 UK patient groups have a positive impression of pharma firms, attributable to only 43% of groups partnering with them, compared to the global figure of 81%, according to a report by PatientView. The participants criticised the sector for a lack of transparency surrounding pricing policies, clinical data sharing and the funding of external stakeholders, and called for a more patient-centric approach.